KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of KOTHARI FERMENTATION & BIOCHEM LTD. ₹24.63, price ₹39.96, upside -38.4%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range ₹34.01 – ₹126.15 · fair‑value band ₹10.54 – ₹38.72 · the ₹39.96 price screens above the ₹24.63 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow KOTHARI FERMENTATION & BIOCHEM in your weekly email
Every Wednesday you see whether KOTHARI FERMENTATION & BIOCHEM is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Kothari Fermentation and Biochem Limited manufactures and sells yeast and its derivatives in India.
Show more
Kothari Fermentation and Biochem Limited manufactures and sells yeast and its derivatives in India. It offers distiller's instant yeast for use in alcohol fermentation; fresh, instant, and inactive dried yeast for use in the food industry; yeast extract powder and inactive dried yeast for use in the pharmaceutical industry; and live yeast and oligo saccharides for use in the veterinary industry. The company offers its products under the Sunrise, KF, and Four Seasons brand names. Kothari Fermentation and Biochem Limited also exports its products to various countries. The company was incorporated in 1990 and is based in New Delhi, India.
Stock analysis
KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL) currently trades at ₹39.96, while our model-based Fair Value estimate is ₹24.63, 38.4% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: ₹10.54 (bear) to ₹38.72 (bull), the price of ₹39.96 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Consumer Non-Cyclicals sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
KOTHARI FERMENTATION & BIOCHEM LTD. reported revenue of ₹1.1B in FY2026 versus ₹970M in FY2022, a compound +3.7%/yr. Reported net income was −₹29.9M in FY2026.
Key figures
Market cap ₹599M (≈ $6.2M) · P/S ratio 0.53 · EPS (TTM) ₹−1.20 · Net margin −2.7% · Return on equity −5.4% · Return on assets (EBIT) 6.2% · Operating margin 3.0% · Revenue (TTM) ₹1.2B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 21% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at −24% fair-value upside, at −38%, KFBL screens richer than that median.
Fair Value models
Bear ₹10.54Fair Value ₹24.63Bull ₹38.72
Price ₹39.96 · Upside -38.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.13/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−1.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
Start year 2021 (pandemic). Over 10 years: +3.8% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.2%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
9.6% (2021) → −0.4% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Compare KOTHARI FERMENTATION & BIOCHEM LTD. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Food & Tobacco · 27 stocks
Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score42 · Bottom 25%
Fair Value upside−38.4% · Bottom 25%
Profitability
Return on assets0.1% · Above median
Net margin (TTM)−1.5% · Bottom 25%
Operating margin (TTM)3.0% · Above median
Growth and dividend
Revenue growth28.0% · Top 25%
Balance sheet
Debt / equity0.79× · Highest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 68
FUTURE (revenue growth)100· sector 0
PAST (return on equity)0· sector 0
HEALTH (low debt)60· sector 97
DIVIDEND (yield)0· sector 63
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹24.63 versus a price of ₹39.96, about −38% upside (overvalued).
What is the fair value of KFBL?
Our model-based fair value for KOTHARI FERMENTATION & BIOCHEM LTD. is ₹24.63 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹39.96.
What is the quality score of KFBL?
KOTHARI FERMENTATION & BIOCHEM LTD. has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
Our model-based price target is the fair value of ₹24.63 (as of Sep 27, 2026) from 2 valuation models. Cautious scenario ₹10.54, optimistic scenario ₹38.72. It is a calculation from audited fundamentals, not an analyst target.
What is the KOTHARI FERMENTATION & BIOCHEM LTD. stock forecast for 2026?
Our models put fair value at ₹24.63, about −38% upside versus a price of ₹39.96 (overvalued). Cautious scenario ₹10.54, optimistic scenario ₹38.72. The calculation is refreshed regularly with new filings.
What is the revenue of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
KOTHARI FERMENTATION & BIOCHEM LTD. reported trailing-twelve-month revenue of about ₹1.2B (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For KOTHARI FERMENTATION & BIOCHEM LTD. it is ₹24.63 per share (as of Sep 27, 2026), against a price of ₹39.96. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is KOTHARI FERMENTATION & BIOCHEM LTD. stock overvalued or undervalued in 2026?
As of Sep 27, 2026, KFBL trades above its calculated fair value: price ₹39.96, fair value ₹24.63, a gap of about −38% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KFBL?
No. The price is what the market pays today (₹39.96); the fair value is what the company's own numbers justify (₹24.63). For KOTHARI FERMENTATION & BIOCHEM LTD. the two are ₹15.33 per share apart. That gap is exactly why we show both numbers side by side.
How much is KOTHARI FERMENTATION & BIOCHEM LTD. worth?
The market values KOTHARI FERMENTATION & BIOCHEM LTD. at about ₹599M (market capitalisation, as of Sep 27, 2026). Per share that is ₹39.96; our models calculate a fair value of ₹24.63 per share.
What do the bullish and bearish scenarios say about KFBL?
Our models span a range for KOTHARI FERMENTATION & BIOCHEM LTD.: cautious scenario ₹10.54, base ₹24.63, optimistic ₹38.72 per share (as of Sep 27, 2026, price ₹39.96). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
Balance-sheet figures for KOTHARI FERMENTATION & BIOCHEM LTD. (as of Sep 27, 2026): return on equity −5.4%, debt of 0.79 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is KFBL from its 52-week high?
KOTHARI FERMENTATION & BIOCHEM LTD. trades at ₹39.96, about 21% below its 52-week high of ₹50.75 and 17% above the low of ₹34.01 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹24.63 is for.
Which stocks are comparable to KOTHARI FERMENTATION & BIOCHEM LTD.?
From the same area (Consumer Non-Cyclicals) we also value FB, URC, MONDE, CNPF, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is KOTHARI FERMENTATION & BIOCHEM LTD. stock attractive at the current price?
The data as of Sep 27, 2026: price ₹39.96, calculated fair value ₹24.63 (−38%), Quality Score 42/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KFBL calculated?
We run KOTHARI FERMENTATION & BIOCHEM LTD. through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹24.63, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. KOTHARI FERMENTATION & BIOCHEM LTD. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
The closing price on Oct 1, 2026 was ₹39.96. Our model-based fair value is ₹24.63, about −38% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with KOTHARI FERMENTATION & BIOCHEM LTD. right now?
The price sits above even our optimistic bull case (₹38.72). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (₹10.54 to ₹38.72). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of KOTHARI FERMENTATION & BIOCHEM LTD.
How large is the market capitalisation of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
The market capitalisation of KOTHARI FERMENTATION & BIOCHEM LTD. is ₹599M (≈ $6.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
The price-to-sales ratio of KOTHARI FERMENTATION & BIOCHEM LTD. is 0.53 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
Earnings per share at KOTHARI FERMENTATION & BIOCHEM LTD. are ₹−1.20. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
The net margin of KOTHARI FERMENTATION & BIOCHEM LTD. is −2.7% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
The return on equity (ROE) of KOTHARI FERMENTATION & BIOCHEM LTD. is −5.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
On an EBIT basis the return on assets of KOTHARI FERMENTATION & BIOCHEM LTD. is 6.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
The operating margin of KOTHARI FERMENTATION & BIOCHEM LTD. is 3.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
Revenue at KOTHARI FERMENTATION & BIOCHEM LTD. is growing +28.0% versus a year earlier (3y avg +0.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL)?
Earnings per share at KOTHARI FERMENTATION & BIOCHEM LTD. are growing +21.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL) generate?
The free cash flow of KOTHARI FERMENTATION & BIOCHEM LTD. is −₹8.5M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL) carry?
The net debt of KOTHARI FERMENTATION & BIOCHEM LTD. is ₹476M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch KOTHARI FERMENTATION & BIOCHEM LTD. in the live analysis
One click puts KOTHARI FERMENTATION & BIOCHEM LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
